BeStock  
Stocks › Biotechnology › FTH

Faeth Therapeutics FTH

US equityMarket cap rank #3739Biotechnology
$7.88 −$0.81 (-9.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.88 0.00%
Open$8.52
Prev close$8.69
Day range$7.84 – $9.13
Volume419.1K
Market cap$203.65M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$22.09M-355.3% YoY
Net profit-$20.40M-346.4% YoY
Diluted EPS-$0.79+78.2% YoY
Free cash flow-$13.01M-262.7% YoY
Operating cash flow-$13.00M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-7.8MDec '24$-6.9MMar '25$-4.9MJun '25$-4.6MSep '25$-4.7MDec '25$-170.2MMar '26$-16.0MJun '26$-20.4MSep '26

Diluted EPS by quarter

-6.17Dec '24-5.45Mar '25-3.91Jun '25-3.62Sep '25-3.74Dec '25-131.45Mar '26-2.84Jun '26-0.79Sep '26

Free cash flow by quarter

$-5.8MDec '24$-7.1MMar '25$-5.9MJun '25$-3.6MSep '25$-3.9MDec '25$-10.7MMar '26$-15.7MJun '26$-13.0MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-229.6%
Return on assets-204.7%
Return on invested capital-232.0%
Current ratio16.12
Liabilities / assets10.0%
Cash & investments$174.80M
Total debt$0.00
Net cash (debt)$174.80M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $22.09M $18.39M $170.63M $22.29M $4.96M
Selling and Admin Expenses $10.35M $9.21M $19.71M $11.33M $2.79M
-General & Admin Expense $10.35M $9.21M $19.71M $11.33M $2.79M
Research & Development $11.74M $9.18M $150.91M $10.96M $2.17M
Operating Profit -$22.09M -$18.39M -$170.63M -$22.29M -$4.96M
Net Non-Operating Interest Income (Expense) $1.78M $2.26M $392,000.00 $1.21M $220,000.00
Non-Operating Interest Income $1.78M $2.26M $392,000.00 $1.24M $252,000.00
Other Income (Expense) -$88,000.00 $120,000.00 -$1,000.00 -$4,000.00 $20,000.00
Other Non-Operating Income (Expenses) -$88,000.00 $120,000.00 -$1,000.00 -$4,000.00 $20,000.00
Pretax Profit -$20.40M -$16.01M -$170.24M -$21.09M -$4.72M
Net Profit -$20.40M -$16.01M -$170.24M -$21.09M -$4.72M
Profit from Continuing Operations -$20.40M -$16.01M -$170.24M -$21.09M -$4.72M
Net Income to Parent Company -$20.40M -$16.01M -$170.24M -$21.09M -$4.72M
Net Income to Common Stockholders -$20.40M -$16.01M -$170.24M -$21.09M -$4.72M
Basic EPS -$0.79 -$2.84 -$131.45 -$16.72 -$3.74
Diluted EPS -$0.79 -$2.84 -$131.45 -$16.72 -$3.74
Non-Operating Interest Expense – – – $32,000.00 $3,000.00
Special Income (Charges) – – – $0.00 $21,000.00
-Less:Impairment of Capital Assets – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $178.95M $189.31M $205.38M $22.90M $22.90M
Total Current Assets $177.84M $188.66M $204.23M $21.51M $21.51M
Cash and Cash Equivalents & Short-Term Investments $174.80M $186.44M $202.79M $21.18M $21.18M
-Cash and Cash Equivalents $14.18M $26.90M $152.33M $8.67M $8.67M
-Short Term Investments $160.62M $159.54M $50.47M $12.52M $12.52M
Prepaid Assets $1.41M $1.36M $974,000.00 $231,000.00 $231,000.00
Other Current Assets $1.63M $858,000.00 $465,000.00 $92,000.00 $92,000.00
Total Non-Current Assets $1.11M $648,000.00 $1.15M $1.40M $1.40M
Net PPE $127,000.00 $568,000.00 $982,000.00 $1.38M $1.38M
-Gross PPE $646,000.00 $1.17M $1.56M $1.92M $1.92M
-Accumulated Depreciation -$519,000.00 -$606,000.00 -$581,000.00 -$540,000.00 -$540,000.00
Other Non-Current Assets $981,000.00 $80,000.00 $167,000.00 $18,000.00 $18,000.00
Total Liabilities $17.85M $16.35M $342.67M $4.31M $4.31M
Total Current Liabilities $11.03M $9.58M $14.19M $4.25M $4.25M
Payables $2.99M $2.15M $3.42M $689,000.00 $689,000.00
-Accounts Payable $2.99M $2.15M $3.42M $689,000.00 $689,000.00
Current Accrued Expenses $5.42M $5.25M $5.43M $715,000.00 $715,000.00
Short-Term Debt and Capital Lease Obligation $145,000.00 $592,000.00 $1.04M $1.45M $1.45M
-Current Capital Lease Obligation $145,000.00 $592,000.00 $1.04M $1.45M $1.45M
Other Current Liabilities $223,000.00 $175,000.00 $136,000.00 $77,000.00 $77,000.00
Total Non-Current Liabilities $6.82M $6.77M $328.48M $59,000.00 $59,000.00
Long Term Debt and Capital Lease Obligation $0.00 $0.00 $1,000.00 $59,000.00 $59,000.00
-Long Term Capital Lease Obligation $0.00 $0.00 $1,000.00 $59,000.00 $59,000.00
Convertible preferred securities $6.77M $6.77M $328.48M – –
Other Non-Current Liabilities $53,000.00 $1,000.00 – – –
Total Equity $161.10M $172.96M -$137.29M $18.59M $18.59M
Stockholders' Equity $161.10M $172.96M -$137.29M $18.59M $18.59M
Capital Stock $3,000.00 $2,000.00 $0.00 $0.00 $0.00
-Common Stock $3,000.00 $2,000.00 $0.00 $0.00 $0.00
-Preferred Stock $0.00 $0.00 – $0.00 $0.00
Additional Paid-In Capital $651.03M $642.40M $316.11M $301.73M $301.73M
Retained Earnings -$489.78M -$469.38M -$453.37M -$283.14M -$283.14M
Gains/Losses Not Affecting Retained Earnings -$153,000.00 -$63,000.00 -$24,000.00 $1,000.00 $1,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$13.00M -$15.67M -$10.73M -$20.45M -$3.86M
Net cash flow from continuing operations -$13.00M -$15.67M -$10.73M -$20.45M -$3.86M
Net Income from Continuing Operations -$20.40M -$16.01M -$170.24M -$21.09M -$4.72M
Depreciation & Depletion & Amortization $17,000.00 $25,000.00 $30,000.00 $139,000.00 $34,000.00
Other Non-Cash Items $398,000.00 $389,000.00 $133.34M $1.51M $374,000.00
Change in Working Capital -$279,000.00 -$3.52M $13.32M -$1.59M $286,000.00
-Change in Prepaid Assets -$54,000.00 -$384,000.00 $10.74M $243,000.00 $266,000.00
-Change in Payables and Accrued Expense $1.17M $243,000.00 -$104,000.00 $233,000.00 $77,000.00
-Change in Other Current Assets -$1.68M -$304,000.00 $442,000.00 $80,000.00 $178,000.00
-Change in Other Current Liabilities -$446,000.00 -$430,000.00 -$407,000.00 -$1.59M -$399,000.00
Net cash flow from investing $175,000.00 -$108.07M -$31.44M $19.77M $2.08M
Net Cash Flow from Continuing Investing Activities $175,000.00 -$108.07M -$31.44M $19.77M $2.08M
Net PPE Purchase and Sale -$3,000.00 $0.00 -$6,000.00 $234,000.00 $0.00
Net Business Purchase and Sale $0.00 $0.00 $6.46M – –
Net Investment Purchase and Sale $178,000.00 -$108.07M -$37.89M $19.54M $2.08M
Financing Cash Flow $104,000.00 -$1.68M $185.83M -$645,000.00 -$111,000.00
Net Cash Flow from Continuing Financing Activities $104,000.00 -$1.68M $185.83M -$645,000.00 -$111,000.00
Net Issuance Payments Of Debt $0.00 -$18,000.00 -$62,000.00 -$648,000.00 -$113,000.00
Net Common Stock Issuance $0.00 – – -$1,000.00 $0.00
Net Preferred Stock Issuance $0.00 -$1.76M $184.86M – –
Proceeds from Stock Option Exercised $104,000.00 $98,000.00 $1.03M $7,000.00 $2,000.00
Ending Cash Balance $14.18M $26.90M $152.33M $8.67M $8.67M
Net Change in Cash -$12.72M -$125.42M $143.66M -$1.33M -$1.89M
Beginning Cash Balance $26.90M $152.33M $8.67M $9.99M $10.56M
Free Cash Flow -$13.01M -$15.67M -$10.74M -$20.47M -$3.86M
-Change In Other Working Capital – – $2.65M -$562,000.00 $164,000.00
Net Other Financing Charges – – – -$3,000.00 $0.00

Discussion

No comments yet — be the first to weigh in on FTH.

Sign in to join the discussion.

Scroll to Top